Limitless Possibilities
Through Exquisite Control

At IFM Therapeutics LLC, we work to improve the lives of patients with inflammatory disorders and cancer by developing transformative medicines that precisely target the innate immune system, the body’s first line of immunological response and an essential component of immune function.
Discover Our Mission arrow-button
down-arrow

Regulating
Immune Response

Serious diseases can result if the immune system consistently under- or over-responds. Our first-in-class medicines precisely control immune responses in patients with inflammatory or autoimmune disorders, and enhance responses in patients with cancer.

Explore Our Approach arrow-button

A Leading Portfolio of
First-in-Class Small Molecules

We are working with urgency to develop novel drugs that meet the needs of patients with inflammatory disorders and cancer.

View Our Pipeline arrow-button

Recent Updates

View All Updates arrow-button
Aug
10
BioCentury Innovations, “The Flip-Side of Immunotherapy”
Aug
07
BioWorld, “BMS looks to ‘marry’ adaptive, innate immunity with $2.32B+ IFM buy”
Aug
03
Endpoints, “Bristol-Myers beefs up big cancer drug pipeline, buying IFM drugs in $2.3B-plus deal”